Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: Clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality

Diabetes Research and Clinical Practice

Volumn 64, Issue 3, 2004, Pages 153-159

  Akahori, Hiroshi ^a   Takamura, Toshinari ^a   Hayakawa, Tetsuo ^a   Ando, Hitoshi ^a   Yamashita, Haruhisa ^a   Kobayashi, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Diabetic peripheral neuropathy; Lipo PGE1; Semmes Weinstein monofilaments

Indexed keywords

MICROSPHERE; PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG FORMULATION; ELECTROCARDIOGRAM; EVALUATION; FEMALE; HUMAN; MALE; MOTOR NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; PERCEPTION; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; QUANTITATIVE ANALYSIS; RR INTERVAL; SEMMES WEINSTEIN MONOFILAMENT; SENSORY DYSFUNCTION; VALIDATION PROCESS;

ALPROSTADIL; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; JAPAN; MALE; MICROSPHERES; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEURONS, AFFERENT; SENSATION DISORDERS; SOMATOSENSORY DISORDERS; TIME FACTORS;

EID: 2342517494     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.012     Document Type: Article

References (12)

1. Hoshi K. Approved indications of Lipo-PGE1 in Japan. Adv. Drug Deliv. Rev. 20:1996;171-176
2. D. LeRoith, S.I. Taylor, J.M. Olefsky, Diabetes Mellitus: a Fundamental and Clinical Text, second ed., 2000, pp. 910-934.
3. Schratzberger P., et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107:2001;1083-1092
4. Schratzberger P., et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6:2000;405-413
5. Sonobe M. Amelioration of nerve Na-K-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206·α-CD in streptozocin-induced diabetic rats. Diabetes. 40:1991;726-730
6. Mizushima Y. Lipid microspheres as novel drug carriers. Drugs Exp. Clin. Res. 11:1985;595-600
7. Hoshi K. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy. Drugs Exp. Clin. Res. 12:1986;681-685
8. Hau P., et al. Screening techniques to identify people at high risk for diabetic foot ulceration. Diabetes Care. 23:2000;606-611
9. Meijer J.-W.G., et al. Diabetic neuropathy examination. Diabetes Care. 23:2000;750-753
10. Nagai Y., Sugiyama Y., et al. Four gram monofilament is clinically useful for detecting diabetic peripheral neuropathy. Diabetes Care. 24:2001;183-184
11. Akira T., et al. Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Med. Postgrad. 37:1999;194-204
12. Kogawa S., Yasuda H., et al. Apoptosis and impaired axonal regeneration of sensory neurons after nerve crush in diabetic rats. Neuroreport. 11(4):2000;663-667